Altimmune stock falls after it drops development of nasal COVID-19 vaccine

Dow Jones2021-06-30

MW Altimmune stock falls after it drops development of nasal COVID-19 vaccine

Altimmune Inc. $(ALT)$ shares dropped in the extended session Tuesday after the biotech said it was discontinuing study of a COVID-19 nasal spray vaccine because it didn't work as well as anticipated. Altimmune shares fell 33% after hours, following a 2.5% decline to close at $15.90. The company called study results of its AdCOVID vaccine "disappointing" and said it would focus on its treatments for obesity and liver disease. "Although antibodies were detected that bound the SARS-CoV-2 Spike protein and neutralized the virus in a subset of subjects, the magnitude of the response and the percent of subjects responding to AdCOVID were substantially lower than what had been demonstrated for other vaccines already authorized for emergency use," Altimmune said in a statement. Shares had gained 53% over the past 12 months, compared with a 41% gain on the S&P 500 index .

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • YsL
    2021-06-30
    YsL
    Loke n comment pls
  • V K
    2021-06-30
    V K
    Like and comment tyvm guys
  • oodumboo
    2021-06-30
    oodumboo
    L leave one comment
  • IsaacYap90
    2021-06-30
    IsaacYap90
    Altimmune Inc. $(ALT)$ shares dropped in the extended session Tuesday after the biotech said it was discontinuing study of a COVID-19 nasal spray vaccine because it didn't work as well as anticipated. 
  • 1Man2Stonks
    2021-06-30
    1Man2Stonks
    Night
    • 1Man2Stonks: 
      sigh..
    • IsaacYap90: 
      Altimmune Inc. $(ALT)$ shares dropped in the extended session Tuesday after the biotech said it was discontinuing study of a COVID-19 nasal spray vaccine because it didn't work as well as anticipated.
  • Rbj
    2021-06-30
    Rbj
    Die la
    • IsaacYap90: 
      Altimmune Inc. $(ALT)$ shares dropped in the extended session Tuesday after the biotech said it was discontinuing study of a COVID-19 nasal spray vaccine because it didn't work as well as anticipated.
Leave a comment
7